v3.25.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning Balance at Dec. 31, 2023 $ 85,077 $ 18 $ 220,185 $ (134,277) $ (849)
Beginning Balance, shares at Dec. 31, 2023   17,532,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) 155     155  
Other comprehensive income (loss) (418)       (418)
Issuance of acquisition-related stock 38,050 $ 3 38,047    
Issuance of acquisition-related stock , shares   3,450,000      
Issuance of restricted stock, shares   12,000      
Stock options exercised 1,257   1,257    
Stock options exercised, shares   171,000      
Stock-based compensation 1,105   1,105    
Ending Balance at Mar. 31, 2024 125,226 $ 21 260,594 (134,122) (1,267)
Ending Balance, shares at Mar. 31, 2024   21,165,000      
Beginning Balance at Dec. 31, 2024 120,604 $ 20 239,983 (118,094) (1,305)
Beginning Balance, shares at Dec. 31, 2024   19,962,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (664)     (664)  
Other comprehensive income (loss) 767       767
Issuance of restricted stock, shares   9,000      
Stock options exercised $ 5   5    
Stock options exercised, shares 640        
Stock-based compensation $ 1,912   1,912    
Repurchase of common stock $ (1,750)   (1,750)    
Repurchase of common stock, shares (100,000) (121,000)      
Ending Balance at Mar. 31, 2025 $ 120,874 $ 20 $ 240,150 $ (118,758) $ (538)
Ending Balance, shares at Mar. 31, 2025   19,850,000